title: Limitation of antiplatelet therapy after percutaneous coronary intervention.
authors.forename: Shosaku
authors.initials: S
authors.lastname: Nomura
authors.forename: Norihito
authors.initials: N
authors.lastname: Inami
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Kimura
authors.forename: Fumiaki
authors.initials: F
authors.lastname: Urase
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Maeda
authors.forename: Toshiji
authors.initials: T
authors.lastname: Iwasaka
mesh_terms: D000789:Angina, Unstable / Q000097:blood; D015906:Angioplasty, Balloon, Coronary; D001779:Blood Coagulation Factors / Q000502:physiology; D018946:Chemokine CCL5 / Q000502:physiology*; D019742:Chemokines, CC / Q000502:physiology; D023903:Coronary Restenosis / Q000097:blood / Q000209:etiology*; D006801:Humans; D007962:Leukocytes / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D001779:Blood Coagulation Factors; C111792:CCL18 protein, human; C483024:CCL5 protein, human; D018946:Chemokine CCL5; D019742:Chemokines, CC; D010975:Platelet Aggregation Inhibitors; C045071:leukocyte procoagulant activity